PeptideStack

5-Amino-1MQ

Discover 5-Amino-1MQ, a potent NNMT inhibitor designed to boost NAD+ levels, enhance cellular metabolism, and promote targeted fat loss in research.

Research Onlyweight lossfat burningsmall molecule

Last updated:

Administration
subcutaneous
Origin
Synthetic (Small Molecule)

Overview

5-Amino-1MQ is a membrane-permeable small molecule that functions as a highly selective inhibitor of nicotinamide N-methyltransferase (NNMT). By blocking this specific enzyme, it prevents the depletion of nicotinamide, leading to a significant and sustained increase in intracellular NAD+ levels. This fundamental metabolic shift enhances cellular energy production, stimulates fat oxidation, and has shown remarkable promise in preclinical models for reversing diet-induced obesity (Neelakantan et al., 2018). Researchers are actively investigating 5-Amino-1MQ benefits for treating metabolic disorders, promoting longevity, and achieving targeted fat loss without altering caloric intake.

Potential Benefits

  • Targeted Fat Loss: Inhibiting the NNMT enzyme significantly reduces white adipose tissue mass and decreases adipocyte volume in animal models without requiring modifications to food intake.
  • Increased NAD+ Levels: The molecule blocks the methylation of nicotinamide, preserving this crucial precursor for the NAD+ salvage pathway to significantly boost overall cellular energy.
  • Enhanced Metabolism: Administration upregulates specific genes associated with energy expenditure and lipid metabolism, effectively reversing diet-induced metabolic slowdown in laboratory settings.
  • Muscle Function Support: Higher NAD+ availability improves mitochondrial function, increases muscle contractility, and promotes the regeneration of aged muscle stem cells in murine models.
  • Potential Anti-Aging Effects: By elevating intracellular NAD+, the compound activates sirtuins (such as SIRT1) which are critical proteins responsible for DNA repair, epigenetic maintenance, and cellular longevity.
  • Cholesterol Management: Preclinical studies suggest that NNMT inhibition may help regulate lipid profiles by lowering total cholesterol and improving overall cardiovascular metabolic markers.

Where to Buy 5-Amino-1MQ

Pinnacle Peptide Labs

View →

Ascension Peptides

View →

Licensed Peptides

View →

These vendors are listed for research reference only. PeptideStack does not endorse, verify, or receive compensation from any vendor. Always verify purity and legitimacy independently.

Side Effects

Common side effects:

  • Mild gastrointestinal discomfort
  • Temporary flushing or warmth
  • Headaches during initial administration
  • Fatigue as metabolic pathways adjust
  • Localized irritation at the injection site

Rare or serious side effects:

  • Unintended severe weight loss
  • Altered cellular methylation pathways
  • Potential liver enzyme fluctuations
  • Unknown long-term metabolic shifts

5-Amino-1MQ is not FDA-approved and is intended for research purposes only. Consult a qualified healthcare provider before use.

Mechanism of Action

NNMT Inhibition is the primary mechanism of action for 5-Amino-1MQ, directly targeting the enzyme responsible for methylating nicotinamide into 1-methylnicotinamide. By blocking this specific biochemical process, the molecule prevents the continuous drain on essential methyl donors like S-adenosylmethionine (SAM) and preserves nicotinamide for the critical NAD+ salvage pathway. This targeted inhibition ensures that cells maintain high levels of energy precursors even under metabolic stress.

Cellular Metabolic Shift occurs as a direct downstream result of these elevated NAD+ levels, which subsequently activates SIRT1 and other NAD+-dependent enzymes. This enzymatic activation enhances mitochondrial biogenesis, significantly increases basal energy expenditure, and shifts the body's metabolism toward utilizing stored white adipose tissue for fuel. Consequently, researchers observe a profound reduction in lipogenesis and an increase in fatty acid oxidation.

Origin & History

Discovery and Development of 5-Amino-1MQ originated from researchers at the University of Texas Medical Branch who were systematically screening for small molecule inhibitors of NNMT to combat metabolic syndrome. They identified this specific quinolinium compound for its exceptionally high efficacy, excellent cellular permeability, and complete lack of off-target effects compared to earlier, less refined iterations (Neelakantan et al., 2018). The development marked a significant milestone in metabolic research.

Regulatory Status remains strictly limited to laboratory and preclinical research environments across the globe. The 5-Amino-1MQ peptide (though technically classified as a small molecule) is not approved by the FDA for human consumption, dietary supplementation, or medical treatment. It is utilized exclusively in highly controlled in vitro and animal studies to explore its anti-obesity properties and broader metabolic implications.

Frequently Asked Questions

Related Peptides

AOD-9604

Research Only

Explore the AOD-9604 peptide, a synthetic HGH fragment researched for targeted fat loss, metabolic enhancement, and weight management benefits.

fat burning

MOTS-c

Research Only

Discover the science behind MOTS-c, a mitochondrial-derived peptide and exercise mimetic. Explore MOTS-c benefits for metabolic health and weight loss.

exercise mimetic

Tesofensine

Research Only

Explore Tesofensine, a potent small molecule researched for extreme appetite suppression and weight loss. Discover Tesofensine benefits and side effects.

appetite suppressionsmall molecule